Agilent Technologies to Acquire MultiplicomPor HospiMedica International plantel de escritores[03 Jan 2017]  |
|
| Agilent Technologies Inc. (Santa Clara, CA, USA) has entered into a definitive agreement to acquire European diagnostics company Multiplicom N.V. (Niel, Belgium), for approximately EUR 68 million in cash. Agilent, which is present in life sciences, diagnostics and applied chemical markets, provides instruments, software, services and consumables for the entire laboratory workflow. Multiplicom develops, manufactures and commercializes molecular-diagnostic solutions, provided as kits. These solutions enable clinical laboratories to identify the DNA variants that are associated with a genetic disease or predisposition in patients, or that may steer cancer therapy or identify congenital defects early in pregnancy. "The acquisition of Multiplicom significantly strengthens our presence in the genomics market," said Herman Verrelst, vice president and general manager of Agilent's Genomics Division. "Multiplicom's products and technology help expand our target-enrichment portfolio and enhance our next-generation sequencing workflow capabilities – providing immediate scale in adjacent markets.” "Multiplicom is excited to be a part of Agilent and for the opportunity to offer our products and technology to a global customer base," said Dirk Pollet, Multiplicom's CEO. Related Links: Agilent Technologies Multiplicom |
|